Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Intervalo de año de publicación
1.
Nanoscale ; 8(33): 15137-41, 2016 Aug 18.
Artículo en Inglés | MEDLINE | ID: mdl-27492928

RESUMEN

The use of exosomes as cancer diagnostic biomarkers is technically limited by their size, heterogeneity and the need for extensive purification and labelling. We report the use of cantilever arrays for simultaneous detection of multiple exosomal surface-antigens with high sensitivity and selectivity. Exosomes from breast cancer were selectively identified by detecting over-expressed membrane-proteins CD24, CD63, and EGFR. Excellent selectivity however, was achieved when targeting the cell-surface proteoglycan, Glypican-1 at extraordinary limits (∼200 exosomes per mL, ∼0.1 pg mL(-1)).


Asunto(s)
Biomarcadores de Tumor/análisis , Neoplasias de la Mama/metabolismo , Antígeno CD24/metabolismo , Receptores ErbB/metabolismo , Exosomas/química , Tetraspanina 30/metabolismo , Línea Celular Tumoral , Humanos , Nanopartículas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA